HIGH-DOSE PYRIDOXINE AND MAGNESIUM ADMINISTRATION IN CHILDREN WITH AUTISTIC DISORDER: AN ABSENCE OF SALUTARY EFFECTS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Saved in:
FINDLING, R.L., ET AL., HIGH-DOSE PYRIDOXINE AND MAGNESIUM ADMINISTRATION IN CHILDREN WITH AUTISTIC DISORDER: AN ABSENCE OF SALUTARY EFFECTS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, Vol. 27, no. 4 (1997), p. 467-478.
Ref.
68358
Location:
SIIS R.237
Palabras clave:
Autismo, Ceguera, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Efectos, Fármacos, Investigación, Trastornos del espectro autista, Tratamiento médico
Autismo, Ceguera, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Efectos, Fármacos, Investigación, Trastornos del espectro autista, Tratamiento médico
Similar Items: HIGH-DOSE PYRIDOXINE AND MAGNESIUM ADMINISTRATION IN CHILDREN WITH AUTISTIC DISORDER: AN ABSENCE OF SALUTARY EFFECTS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
- A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER PILOT TRIAL OF LOW DOSE DIMETHYLGLYCINE IN PATIENTS WITH AUTISTIC DISORDER
- NALTREXONE IN YOUNG AUTISTIC CHILDREN: A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY
- MULTISITE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PORCINE SECRETIN IN AUTISM
- EFFECTS OF NALOXONE AND NALTREXONE ON SELF-INJURY: A DOUBLE-BLIND, PLACEBO-CONTROLLED ANALYSIS
- DOUBLE-BLIND COMPARISON OF CARBAMAZEPINE AND PLACEBO FOR TREATMENT OF COCAINE DEPENDENCE
- OLANZAPINE IN COCAINE DEPENDENCE: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL